CYTOMEGALOVIRUS OESOPHAGITIS side effect
What is CYTOMEGALOVIRUS OESOPHAGITIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CYTOMEGALOVIRUS OESOPHAGITIS and Recently Reported Side Effects
CYTOMEGALOVIRUS OESOPHAGITIS and 15 most Active Side Effect polls
CYTOMEGALOVIRUS OESOPHAGITIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Velcade Side Effects Report #5657952-1
Physician from JAPAN reported VELCADE problem on Feb 22, 2008. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus oesophagitis, . VELCADE dosage: unknown. Patient recovered.
Erlotinib Side Effects Report #5320160-8
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Apr 18, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus oesophagitis, dehydration, diarrhoea, dizziness, dyspnoea exertional, gait disturbance, movement disorder, nausea, . ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Tacrolimus Side Effects Report #5638767-7
Physician from AUSTRALIA reported TACROLIMUS problem on Feb 08, 2008. Female patient, child 9 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, chest pain, cytomegalovirus oesophagitis, haemolytic anaemia, lymphopenia, pyrexia, rash maculo-papular, renal failure, small intestinal obstruction, . TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, AZATHIOPRINEECTION, GANCICLOVIR, PREDNISONE, COTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5564532-5
PROGRAF problem was reported by a Physician from BRAZIL on Nov 27, 2007. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, complications of transplanted kidney, cytomegalovirus oesophagitis, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemodialysis, haemolytic uraemic syndrome, kidney transplant rejection, . PROGRAF dosage: 0.15 MG/KG. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.
Prograf Side Effects Report #5564534-9
Physician from BRAZIL reported PROGRAF problem on Nov 27, 2007. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, complications of transplanted kidney, cytomegalovirus oesophagitis, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemodialysis, haemolytic uraemic syndrome, kidney transplant rejection, . PROGRAF dosage: 0.15 MG/KG. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.
Prograf Side Effects Report #5564536-2
PROGRAF problem was reported by a Physician from BRAZIL on Nov 27, 2007. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, complications of transplanted kidney, cytomegalovirus oesophagitis, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemodialysis, haemolytic uraemic syndrome, kidney transplant rejection, . PROGRAF dosage: 0.15 MG/KG. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.
Prograf Side Effects Report #5564543-X
Physician from BRAZIL reported PROGRAF problem on Nov 27, 2007. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, complications of transplanted kidney, cytomegalovirus oesophagitis, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemodialysis, haemolytic uraemic syndrome, kidney transplant rejection, . PROGRAF dosage: 0.15 MG/KG. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.
Prograf Side Effects Report #5564559-3
PROGRAF problem was reported by a Physician from BRAZIL on Nov 27, 2007. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, complications of transplanted kidney, cytomegalovirus oesophagitis, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemodialysis, haemolytic uraemic syndrome, kidney transplant rejection, . PROGRAF dosage: 0.15 MG/KG. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.
Myfortic Side Effects Report #5368249-1
Consumer or non-health professional from UNITED STATES reported MYFORTIC problem on June 19, 2007. Male patient, 56 years of age, weighting 173.9 lb, was diagnosed with renal transplant, squamous cell carcinoma and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: abscess neck, choking sensation, cytomegalovirus oesophagitis, dysphagia, dysphonia, dyspnoea, herpes oesophagitis, laryngeal stenosis, . MYFORTIC dosage: 720 MG, BID. During the same period patient was treated with CELLCEPT, RAPAMUNE, NEORAL, VALTREX. Patient was hospitalized. Patient died.
Myfortic Side Effects Report #5371650-3
MYFORTIC problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Male patient, 56 years of age, weighting 173.9 lb, was diagnosed with renal transplant, squamous cell carcinoma and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: abscess neck, choking sensation, cytomegalovirus oesophagitis, dysphagia, dysphonia, dyspnoea, herpes oesophagitis, laryngeal stenosis, . MYFORTIC dosage: 720 MG, BID. During the same period patient was treated with CELLCEPT, RAPAMUNE, NEORAL, VALTREX. Patient was hospitalized. Patient died.